• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

弥散加权磁共振成像的基线骨髓表观扩散系数值:新诊断多发性骨髓瘤患者疾病进展和死亡的潜在独立预测指标

Baseline bone marrow ADC value of diffusion-weighted MRI: a potential independent predictor for progression and death in patients with newly diagnosed multiple myeloma.

作者信息

Zhang Lu, Wang Qin, Wu Xia, Zhao Ailin, Feng Jun, Zhang Haibo, Cao Xinxin, Li Shuo, Cai Huacong, Sun Zhaoyong, Duan Minghui, Zhu Tienan, Zhang Wei, Jin Zhengyu, Zhou Daobin, Xue Huadan, Li Jian

机构信息

Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, China.

Department of Radiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, China.

出版信息

Eur Radiol. 2021 Apr;31(4):1843-1852. doi: 10.1007/s00330-020-07295-6. Epub 2020 Sep 23.

DOI:10.1007/s00330-020-07295-6
PMID:32965573
Abstract

OBJECTIVES

To illuminate the prognostic value of ADC (apparent diffusion coefficient), an important quantitative parameter of diffusion-weighted MRI, for multiple myeloma (MM).

METHODS

A prospective single-center study which enrolled 114 consecutive newly diagnosed MM patients with baseline whole-body diffusion-weighted MRI (WB DW-MRI) results was conducted. Baseline clinical and MRI parameters were analyzed with univariate and multivariate approaches to identify independent risk factors for progression-free survival (PFS) and overall survival (OS).

RESULTS

Five different DW-MRI patterns were seen, and the mean ADC value of the representative background bone marrow was 0.4662 ± 0.1939 × 10 mm/s. After a mean follow-up of 50.2 months (range, 15.7-75.8 months), twenty-four patients died and seven were lost to follow-up. The mean ADC value of the representative background bone marrow was showed to be an independent risk factor for both PFS (HR 4.664; 95% confidence interval (CI) 1.138-19.121; p = 0.032) and OS (HR 14.130; 95% CI 1.544-129.299; p = 0.019). Normal/salt-and-pepper pattern on DW-MRI was associated with PFS using univariate analysis (p = 0.035) but lost the significance with multivariate Cox regression.

CONCLUSIONS

Mean ADC value of the representative background bone marrow predicts both PFS and OS which suggests the role of baseline DW-MRI for risk stratification in newly diagnosed MM patients.

KEY POINTS

• Whole-body diffusion-weighted MRI (WB DW-MRI) might be helpful to improve the current risk stratification systems for newly diagnosed multiple myeloma (MM). • Morphological parameters as MRI pattern and focal lesion-associated parameters have been reported to be related to survival. However, important functional parameters such as apparent diffusion coefficient (ADC) values were not incorporated into the current risk stratification model. • This study is one of the first endeavors to delineate the correlation of baseline ADC values and survival in MM patients. It is revealed that the mean ADC value of the representative background bone marrow (L3-S1 and iliac bone) was an independent risk factor for both PFS and OS.

摘要

目的

阐明扩散加权磁共振成像的重要定量参数——表观扩散系数(ADC)对多发性骨髓瘤(MM)的预后价值。

方法

进行了一项前瞻性单中心研究,纳入114例连续的新诊断MM患者,这些患者均有基线全身扩散加权磁共振成像(WB DW-MRI)结果。采用单因素和多因素方法分析基线临床和MRI参数,以确定无进展生存期(PFS)和总生存期(OS)的独立危险因素。

结果

观察到五种不同的DW-MRI模式,代表性背景骨髓的平均ADC值为0.4662±0.1939×10⁻³mm²/s。平均随访50.2个月(范围15.7 - 75.8个月)后,24例患者死亡,7例失访。代表性背景骨髓的平均ADC值被证明是PFS(风险比[HR]4.664;95%置信区间[CI]1.138 - 19.121;p = 0.032)和OS(HR 14.130;95%CI 1.544 - 129.299;p = 0.019)的独立危险因素。DW-MRI上的正常/椒盐模式在单因素分析中与PFS相关(p = 0.035),但在多因素Cox回归中失去显著性。

结论

代表性背景骨髓的平均ADC值可预测PFS和OS,这表明基线DW-MRI在新诊断MM患者风险分层中的作用。

关键点

• 全身扩散加权磁共振成像(WB DW-MRI)可能有助于改进当前新诊断多发性骨髓瘤(MM)的风险分层系统。

• 据报道,MRI模式等形态学参数和局灶性病变相关参数与生存相关。然而,诸如表观扩散系数(ADC)值等重要功能参数未纳入当前风险分层模型。

• 本研究是最早描述MM患者基线ADC值与生存相关性的研究之一。结果显示,代表性背景骨髓(L3 - S1和髂骨)的平均ADC值是PFS和OS的独立危险因素。

相似文献

1
Baseline bone marrow ADC value of diffusion-weighted MRI: a potential independent predictor for progression and death in patients with newly diagnosed multiple myeloma.弥散加权磁共振成像的基线骨髓表观扩散系数值:新诊断多发性骨髓瘤患者疾病进展和死亡的潜在独立预测指标
Eur Radiol. 2021 Apr;31(4):1843-1852. doi: 10.1007/s00330-020-07295-6. Epub 2020 Sep 23.
2
The Apparent Diffusion Coefficient of Diffusion-Weighted Whole-Body Magnetic Resonance Imaging Affects the Survival of Multiple Myeloma Independently.扩散加权全身磁共振成像的表观扩散系数独立影响多发性骨髓瘤的生存期。
Front Oncol. 2022 Mar 4;12:780078. doi: 10.3389/fonc.2022.780078. eCollection 2022.
3
Deep Learning for Automatic Bone Marrow Apparent Diffusion Coefficient Measurements From Whole-Body Magnetic Resonance Imaging in Patients With Multiple Myeloma: A Retrospective Multicenter Study.深度学习在多发性骨髓瘤患者全身磁共振成像中自动骨髓表观扩散系数测量中的应用:一项回顾性多中心研究。
Invest Radiol. 2023 Apr 1;58(4):273-282. doi: 10.1097/RLI.0000000000000932. Epub 2022 Oct 3.
4
Histogram Analysis Based on Apparent Diffusion Coefficient Maps of Bone Marrow in Multiple Myeloma: An Independent Predictor for High-risk Patients Classified by the Revised International Staging System.基于多发性骨髓瘤骨髓表观扩散系数图的直方图分析:修订国际分期系统对高危患者的独立预测指标
Acad Radiol. 2022 Jun;29(6):e98-e107. doi: 10.1016/j.acra.2021.07.010. Epub 2021 Aug 24.
5
Quantitative Whole-Body Diffusion-weighted MRI after One Treatment Cycle for Aggressive Non-Hodgkin Lymphoma Is an Independent Prognostic Factor of Outcome.单治疗周期后全身定量扩散加权 MRI 是侵袭性非霍奇金淋巴瘤的独立预后因素。
Radiol Imaging Cancer. 2021 Mar 26;3(2):e200061. doi: 10.1148/rycan.2021200061. eCollection 2021 Mar.
6
Discriminating Depth of Response to Therapy in Multiple Myeloma Using Whole-body Diffusion-weighted MRI with Apparent Diffusion Coefficient: Preliminary Results From a Single-center Study.使用全身扩散加权 MRI 及其表观扩散系数鉴别多发性骨髓瘤的治疗反应深度:一项单中心研究的初步结果。
Acad Radiol. 2018 Jul;25(7):904-914. doi: 10.1016/j.acra.2017.12.008. Epub 2018 Jan 17.
7
Repeatability and test-retest reproducibility of mean apparent diffusion coefficient measurements of focal and diffuse disease in relapsed multiple myeloma at 3T whole body diffusion-weighted MRI (WB-DW-MRI).在 3T 全身扩散加权 MRI(WB-DW-MRI)中,复发性多发性骨髓瘤的局灶性和弥漫性病变的平均表观扩散系数测量的重复性和测试-再测试可重复性。
Br J Radiol. 2022 Sep 1;95(1138):20220418. doi: 10.1259/bjr.20220418. Epub 2022 Jul 28.
8
Longitudinal monitoring of apparent diffusion coefficient (ADC) in myeloma patients with lower M-gradient levels undergoing systemic treatment and whole-body MRI monitoring.对行全身 MRI 监测及系统性治疗且 M 梯度水平较低的骨髓瘤患者行表观扩散系数(ADC)的纵向监测。
Eur J Radiol. 2020 Nov;132:109306. doi: 10.1016/j.ejrad.2020.109306. Epub 2020 Sep 28.
9
Apparent diffusion coefficient maps integrated in whole-body MRI examination for the evaluation of tumor response to chemotherapy in patients with multiple myeloma.全身MRI检查中整合的表观扩散系数图用于评估多发性骨髓瘤患者对化疗的肿瘤反应。
Acad Radiol. 2015 Sep;22(9):1163-71. doi: 10.1016/j.acra.2015.05.011. Epub 2015 Jul 14.
10
Assessing the relation between bone marrow signal intensity and apparent diffusion coefficient in diffusion-weighted MRI.评估弥散加权 MRI 中骨髓信号强度与表观弥散系数之间的关系。
AJR Am J Roentgenol. 2013 Jan;200(1):163-70. doi: 10.2214/AJR.11.8185.

引用本文的文献

1
Diffusion weighted imaging in musculoskeletal system: where are we now?肌肉骨骼系统中的扩散加权成像:我们目前处于什么阶段?
BJR Open. 2025 Jul 22;7(1):tzaf019. doi: 10.1093/bjro/tzaf019. eCollection 2025 Jan.
2
Evidence-based Korean guidelines for the clinical management of multiple myeloma: addressing 12 key clinical questions.基于证据的韩国多发性骨髓瘤临床管理指南:解决12个关键临床问题。
Blood Res. 2025 Feb 4;60(1):9. doi: 10.1007/s44313-025-00055-9.
3
Recent advances in imaging and artificial intelligence (AI) for quantitative assessment of multiple myeloma.

本文引用的文献

1
DCE-MRI-Derived Volume Transfer Constant (K) and DWI Apparent Diffusion Coefficient as Predictive Markers of Short- and Long-Term Efficacy of Chemoradiotherapy in Patients With Esophageal Cancer.基于动态对比增强磁共振成像(DCE-MRI)得出的容积转移常数(K)和弥散加权成像(DWI)表观扩散系数作为食管癌患者放化疗短期和长期疗效的预测指标
Technol Cancer Res Treat. 2018 Jan 1;17:1533034618765254. doi: 10.1177/1533034618765254.
2
Extent of disease burden determined with magnetic resonance imaging of the bone marrow is predictive of survival outcome in patients with multiple myeloma.骨髓磁共振成像确定的疾病负担程度可预测多发性骨髓瘤患者的生存结局。
Cancer. 2010 Jan 1;116(1):84-92. doi: 10.1002/cncr.24704.
用于多发性骨髓瘤定量评估的成像和人工智能(AI)的最新进展。
Am J Nucl Med Mol Imaging. 2024 Aug 25;14(4):208-229. doi: 10.62347/NLLV9295. eCollection 2024.
4
3D CNN-based Deep Learning Model-based Explanatory Prognostication in Patients  with Multiple Myeloma using Whole-body MRI.基于 3D CNN 的深度学习模型对多发性骨髓瘤患者进行全身 MRI 解释预后预测。
J Med Syst. 2024 Mar 8;48(1):30. doi: 10.1007/s10916-024-02040-8.
5
Imaging of Multiple Myeloma: Present and Future.多发性骨髓瘤的影像学:现状与未来。
J Clin Med. 2024 Jan 2;13(1):264. doi: 10.3390/jcm13010264.
6
Applications of Diffusion-Weighted MRI to the Musculoskeletal System.扩散加权 MRI 在肌肉骨骼系统中的应用。
J Magn Reson Imaging. 2024 Feb;59(2):376-396. doi: 10.1002/jmri.28870. Epub 2023 Jul 21.
7
[The guidelines for diagnosis and treatment of myeloma bone disease in China (2022)].《中国骨髓瘤骨病诊断与治疗指南(2022年版)》
Zhonghua Xue Ye Xue Za Zhi. 2022 Dec 14;43(12):979-985. doi: 10.3760/cma.j.issn.0253-2727.2022.12.002.
8
Whole-body MRI in oncology: can a single anatomic T2 Dixon sequence replace the combination of T1 and STIR sequences to detect skeletal metastasis and myeloma?全身 MRI 在肿瘤学中的应用:单个解剖 T2 Dixon 序列是否可以替代 T1 和 STIR 序列的组合来检测骨骼转移和骨髓瘤?
Eur Radiol. 2023 Jan;33(1):244-257. doi: 10.1007/s00330-022-09007-8. Epub 2022 Aug 4.
9
Progress of modern imaging modalities in multiple myeloma.多发性骨髓瘤的现代影像学进展。
Int J Hematol. 2022 Jun;115(6):778-789. doi: 10.1007/s12185-022-03360-6. Epub 2022 May 9.
10
Modern radiographic imaging in multiple myeloma, what is the minimum requirement?多发性骨髓瘤的现代放射影像学检查:最低要求是什么?
Semin Oncol. 2022 Feb;49(1):86-93. doi: 10.1053/j.seminoncol.2022.01.007. Epub 2022 Jan 20.